Analyst Reco. Ocugen, Inc.

Equities

OCGN

US67577C1053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
1.91 ^USD	-3.54%		+20.13%	+232.17%

May. 15	Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study	MT
May. 15	Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST?A Modifier Gene Therapy	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating	Apr. 22	MT
Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating	Apr. 22	MT
HC Wainwright Adjusts Price Target on Ocugen to $7 From $5, Maintains Buy Rating	Jan. 24	MT
Cantor Fitzgerald Adjusts Ocugen's Price Target to $2 From $2.50, Keeps Overweight Rating	23-08-31	MT
Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept	23-05-08	MT
Chardan Upgrades Ocugen to Buy From Neutral, Citing Recent Sell-Off	23-03-01	MT
Mizuho Adjusts Price Target on Ocugen to $3 From $5, Maintains Buy Rating	23-03-01	MT
Mizuho Securities Starts Ocugen at Buy With $5 Price Target	22-08-23	MT
HC Wainwright Adjusts Ocugen's Price Target to $6 from $7, Maintains Buy Rating	22-08-15	MT
Roth Capital Reinstates Ocugen at Buy with $8 Price Target	22-06-15	MT
Cantor Fitzgerald Starts Ocugen at Overweight With $4.50 Price Target	22-06-02	MT
Chardan Trims Ocugen's Price Targe to $3.50 From $4, Maintains Neutral Rating	22-05-09	MT
Chardan Research Adjusts Ocugen's Price Target to $3.50 From $4, Maintains Neutral Rating	22-05-09	MT
HC Wainwright Adjusts Ocugen's Price Target to $8 from $10, Maintains Buy Rating	22-02-28	MT
ANALYST RECOMMENDATIONS : Alliant Energy, Ally Financial, Alphabet, HSBC, Honest...	21-06-14
OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $4 From $11, Maintains Neutral Rating	21-06-11	MT
OCUGEN : Chardan Adjusts Ocugen PT to $4.50 From $8, Maintains Neutral Rating	21-06-11	MT
OCUGEN : HC Wainwright Adjusts Ocugen's Price Target to $10 From $12, Maintains Buy Rating	21-06-11	MT
OCUGEN : Roth Capital Cuts Ocugen to Neutral From Buy, Price Target to $6 From $10	21-06-11	MT
OCUGEN : Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating	21-05-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ocugen, Inc.

Equities

OCGN

US67577C1053

Analyst Reco.

Filters